2030 Access Treatment 
MGC Pharma
FEBRUARY 22, 2018
According to the Australian Bureau of Statistics, the number of people aged 65 years or older is expected to exceed the number of children aged 14 and below by as soon as 2030. of respondents who received Medical Cannabis treatment reported improvement in their condition and significant reductions to pain levels.
Cannabis Law Report
JUNE 20, 2021
On June 18, 2021, Palo Santo , the leading psychedelic investment fund helping to increase the supply of clinically effective and accessible mental health and addiction treatment solutions, issued the following statement regarding atai Life Sciences’ (“atai” or “Company”) ( NASDAQ: ATAI ) initial public offering. . trillion by 2030.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
JUNE 19, 2021
June 18, 2021 (Chicago) — Palo Santo , the leading psychedelic investment fund helping to increase the supply of clinically effective and accessible mental health and addiction treatment solutions, issued the following statement regarding atai Life Sciences ’ (“atai” or “Company”) ( NASDAQ: ATAI ) initial public offering.
Cannabis Law Report
DECEMBER 17, 2021
Deletion Syndrome – Global Market Insights, Epidemiology and Forecast to 2030” report has been added to ResearchAndMarkets.com’s offering. deletion syndrome in the 7MM covering United States, EU5 countries (Germany, France, Italy, Spain, and United Kingdom), and Japan from 2018 to 2030. Country-Wise Epidemiology.
Veriheal
JANUARY 21, 2025
For example, California, New York, and New Jersey have similar requirements in place, providing a framework for the fair treatment of cannabis workers and setting the stage for Oregon to follow suit. billion by 2030. Labor peace agreements are already a fixture in other states with established cannabis industries.
Cannabis Law Report
JUNE 24, 2021
More investment is needed for research into the harm that the non-medical use of cannabis poses to health and to better define the range of health conditions for which cannabis products may be an effective treatment. Drug Use Rising, but Science-Based Treatment More Available. The Dark Web. The Drug Market Rebounds and Shifts.
The Cannigma
OCTOBER 20, 2021
In a June, 2020 interview, a Swiss drug policy expert told Marijuana Business Daily that the scientific process behind the pilot program is expected to last five years, and that if everything goes as planned, the matter of full recreational cannabis legalization for adults could be debated by 2030. How do the Swiss generally view marijuana?
Expert insights. Personalized for you.
Let's personalize your content